Trendlines Group retweeted
Phytolon חברת הפורטפוליו של טרנדליינס השלימה גיוס B למסחור צבעי המאכל הטבעיים החדשניים שלה dlvr.it/TSk9xp
Congrats!
Phytolon raises $23.6 million Series B to scale natural food color production.
Israeli biotech targets US market with fermentation-based alternatives to synthetic dyes.
calcalistech.com/ctechnews/a…
Trendlines Group retweeted
הסטארטאפ הישראלי שמייצר צבעי מאכל טבעיים גייס עוד 24 מיליון דולר
geektime.co.il/phytolon-rais…
Trendlines Group retweeted
IBI Ag’s AI Breakthrough 🧬
IBI Ag finalized a proof of concept for the first AI platform that designs bioinsecticide proteins from scratch. These "de novo" proteins target specific pests while remaining safe for beneficial insects and lowering production costs.
Trendlines Group retweeted
Trendlines portfolio company IBI Ag completes proof of concept for AI-driven platform of novel bioinsecticide proteins dlvr.it/TRRrjj
Congrats to the IBI Ag team!
@TrendlinesAg
IBI-Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, today announced the successful completion of its Series A funding round for a total of $10 million. #AgTech #Funding #biotech
agreads.com/2025/11/11/ibi-a…
Trendlines Group retweeted
IBI-Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, today announced the successful completion of its Series A funding round for a total of $10 million. #AgTech #Funding #biotech
agreads.com/2025/11/11/ibi-a…
Way to go Escala Medical. Thanks @AmySpiro and @Calcalistech for running the story!
Really proud of Edit and the team for this! Thanks to @AmySpiro and @Calcalistech for publishing! Escala Medical raises $4.5M Series A for safer pelvic prolapse treatment #womenshealth calcalistech.com/ctechnews/a…
Trendlines Group retweeted
#Escala Secures $4.5M in #Funding to Accelerate #Global #Expansion of Its #FDA-#Approved #Medical #Device tinyurl.com/38x54k3f $TRNLY
Trendlines Group retweeted
🌱 EU Soil Monitoring Law adopted! A big step for sustainable land by 2050. TierraSpec’s soil monitoring tech supports healthier soils. 🌍
👉 Contact TierraSpec.com to get started!
Kudos to @DCAAarhusUni, @Green_Europe, & @AI4SoilHealth!
🔗 dca.au.dk/en/current-news/ne…
#SoilHealth #EUSoilLaw #agtech #soil @TrendlinesGroup
היום ב-12:00: ישראל עוצרת!
היום ב־12:00 נעצור שוב – כי אין ברירה אחרת. אנחנו עוצרים כדי להשפיע על המציאות, כדי לומר לחברים בעבודה, לשכנים, ולממשלה: לא נוותר על החטופים. לא נוותר על שלטון החוק והדמוקרטיה. ולא נקבל את המלחמה כגורל.
#Israelstops
Trendlines Group retweeted
Qiagen buys Israeli AI software co Genoox: iglob.es/?en1510153 | via @GlobesEnglish
Trendlines Group retweeted
Do you believe the larger size of #robotic trocars compared to #laparoscopic trocars are responsible for increase port related complications (acute, long term hernia, etc)? @IntuitiveSurg
70%Yes
30%No
23 votes • Final results Trendlines Group retweeted
FDA OKs Arcuro Medical’s SuperBall RC for #rotatorcuff repair:
hubs.li/Q038BnCn0
Trendlines Group retweeted
#Arcuro #Medical #Announces #FDA 510(k) #Clearance for the #SuperBall RC for #Rotator #Cuff #Indications tinyurl.com/bdz2bkds $TRNLY
Congrats IBI Ag!
IBI Ag secures $6.1 million to bring pharma-inspired crop protection to farms | Ctech @Calcalistech calcalistech.com/ctechnews/a…
Extremely proud of portfolio company IBI-Ag. Onwards and upwards!
IBI Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, announced it has successfully closed the first part of its Series A funding round with a $6.1 million investment. #Agriculture
agreads.com/2025/02/14/ibi-a…
Trendlines Group retweeted
🏢 Arcuro Medical
📍 Israel
🏗️ Healthcare & Life Sciences
💰 undisclosed Series A
🤝 Investors: Consensus Business Group, Varana Capital (Ezra Gardner), Trendlines
🔗 vcguru.ai/company/677c28e71d…
📝 Arcuro Medical, founded in Israel with U.S. operations in Minneapolis, Minnesota, and Naples, Florida, has secured a Series A financing round led by Varana Capital. The round, which remains open for additional investment, also saw participation from Trendlines and Consensus Business Group. This funding will support Arcuro's growth and innovation in the medical device industry, particularly in orthopedic solutions. Arcuro Medical, a portfolio company of The Trendlines Group, achieved significant milestones in 2024, including a new U.S. organization, key sales leadership hires, and a 510(k) submission for a new product line. The company is poised for substantial growth in 2025, leveraging its expanded distribution network and enhanced product portfolio.
#Startup #Funding #Arcuro Medical



















